CALT - Cup and HandleAn idea showing a clear Cup or rounded formation on CALT.
Im just forecasting a handle situation due to the fact of the presence of this cup.
Price is above a down channel which is good for this scenario.
−8.7SEK
−466.19 MSEK
1.21 BSEK
38.11 M
About CALLIDITAS THERAPEUTICS AB SER'B'NPV
Sector
CEO
Renée Julie Elisabet Aguiar-Lucander
Headquarters
Stockholm
Website
Founded
2004
ISIN
SE0010441584
FIGI
BBG00Y4QYB65
Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN. The firm product TARPEYO is used to reduce proteinuria in adults with primary immunoglobulin. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.
CALT BUY/LONG NOW READY! 31.00 to 39.45 by Aug 2021TICKER CODE: CALT
Company Name: CALLIDITAS THERAPEUTICS AB
US Stocks Health Technology Pharmaceuticals: Major
Position Proposed: BUY
BUY ENTRY: NOW READY (31.00)
1st Partial Take Profit: 39.45 (July - August 2021)
2nd Partial Take Profit: 47.80 (End 2021)
NOTE THAT THE TIMELINE IS ONLY AN ESTIMA
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0A5R is 101.2 SEK — it has increased by 0.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CALLIDITAS THERAPEUTICS AB SER'B'NPV stocks are traded under the ticker 0A5R.
CALLIDITAS THERAPEUTICS AB SER'B'NPV is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
0A5R stock is 2.19% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is CALLIDITAS THERAPEUTICS AB SER'B'NPV there?
0A5R earnings for the last quarter are −0.17 SEK per share, whereas the estimation was −0.71 SEK resulting in a 76.18% surprise. The estimated earnings for the next quarter are −0.94 SEK per share. See more details about CALLIDITAS THERAPEUTICS AB SER'B'NPV earnings.
CALLIDITAS THERAPEUTICS AB SER'B'NPV revenue for the last quarter amounts to 294.60 M SEK despite the estimated figure of 325.23 M SEK. In the next quarter revenue is expected to reach 360.45 M SEK.
Yes, you can track CALLIDITAS THERAPEUTICS AB SER'B'NPV financials in yearly and quarterly reports right on TradingView.
0A5R stock has risen by 0.76% compared to the previous week, the month change is a 11.26% fall, over the last year CALLIDITAS THERAPEUTICS AB SER'B'NPV has showed a 20.53% decrease.
0A5R net income for the last quarter is −18.37 M SEK, while the quarter before that showed −168.36 M SEK of net income which accounts for 89.09% change. Track more CALLIDITAS THERAPEUTICS AB SER'B'NPV financial stats to get the full picture.
Today CALLIDITAS THERAPEUTICS AB SER'B'NPV has the market capitalization of 5.38 B, it has decreased by 4.55% over the last week.
No, 0A5R doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0A5R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CALLIDITAS THERAPEUTICS AB SER'B'NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CALLIDITAS THERAPEUTICS AB SER'B'NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CALLIDITAS THERAPEUTICS AB SER'B'NPV stock shows the sell signal. See more of CALLIDITAS THERAPEUTICS AB SER'B'NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CALLIDITAS THERAPEUTICS AB SER'B'NPV future price: according to them, 0A5R price has a max estimate of 300.00 SEK and a min estimate of 89.91 SEK. Read a more detailed CALLIDITAS THERAPEUTICS AB SER'B'NPV forecast: see what analysts think of CALLIDITAS THERAPEUTICS AB SER'B'NPV and suggest that you do with its stocks.